Self-Medication Among Medical Students During the COVID19 Pandemic
DOI:
https://doi.org/10.55489/njcm.140520232855Keywords:
Self -medication, pandemic, covid-19, medical student, paracetamolAbstract
Introduction: During the different wave of pandemic, due to various reasons self-medication practices among the public increased. Medical students are prone to such practices due to relevant background knowledge, and access to drugs. This study assessed the self-medication practice among the medial students during the different waves of pandemic of south Gujarat.
Material and Methods: This descriptive study was conducted during May to June 2022 through self-administered form among medical students of south Gujarat, India. Study questionnaire included general demography; most frequently practice of self-medication. drug and the reason behind it.
Result: Out of total 512 respondents, 381 (74.4%) did self-medication during the pandemic. 358 individuals (94.0%) did self-medication at least one drug since the start of pandemic. The most commonly utilizing medicines as prophylactic was Ayurvedic preparation, Multivitamins, Zinc and Vitamin C. For treatment of symptoms during the pandemic paracetamol (650 mg) was frequently used specially for body ache and fever. The main source of information of self-medication was internet.
Conclusion: This study depicted common self-medication practices among medical students during the pandemic. It is a significant health issue especially during the pandemic times, with high consumption reported as a prevention or treating symptoms of COVID-19.
References
Yasmin, F., Asghar, M. S., Naeem, U., Najeeb, H., Nauman, H., Ah-san, M. N., & Khattak, A. K. (2022). Self-Medication Practices in Medical Students During the COVID-19 Pandemic: A Cross-Sectional Analysis. Frontiers in public health, 2022;10: 803937. Doi: https://doi.org/10.3389/fpubh.2022.803937 PMid:35356012 PMCid:PMC8959567
WHO. Coronavirus (COVID-19) Dashboard | WHO Corona-virus (COVID-19) Dashboard With Vaccination Data. Availa-ble online at: https://covid19.who.int/.2
WHO. Director-General's Opening Remarks at the Media Briefing on COVID-19. Available online at: https://www.who.int/ director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020 (accessed May 16, 2021).
Acharya A, Shrestha MV, Karki D. Self-medication among Med-ical Students and Staffs of a Tertiary Care Centre during COVID-19 Pandemic: A Descriptive Cross-sectional Study. JNMA J Nepal Med Assoc. 2022 Jan 15;60(245):59-62. Doi: https://doi.org/10.31729/jnma.7247 PMid:35199665 PMCid:PMC9157655
World Health Organization. (1998). The Role of the pharma-cist in self-care and self-medication : report of the 4th WHO Consultative Group on the Role of the Pharmacist, The Hague, The Netherlands, 26-28 August 1998. World Health Organiza-tion. https://apps.who.int/iris/handle/10665/65860
Baracaldo-Santamaría D, Pabón-Londoño S, Rojas-Rodriguez LC. Drug safety of frequently used drugs and substances for self-medication in COVID-19. Ther Adv Drug Saf. 2022; 21;13: 20420986221094141. Doi:https://doi.org/10.1177/20420986221094141 PMid:35493401 PMCid:PMC9039440
Noreen, K., Rubab, Z. E., Umar, M., Rehman, R., Baig, M., & Baig, F. Knowledge, attitudes, and practices against the growing threat of COVID-19 among medical students of Pakistan. PloS one 2020; 15(12): e0243696. Doi: https://doi.org/10.1371/journal.pone.0243696 PMid:33306712 PMCid:PMC7732088
Malik M, Tahir MJ, Jabbar R, Ahmed A, Hussain R. Self-medication during Covid-19 pandemic: challenges and oppor-tunities. Drugs Ther Perspect. 2020;36(12):565-567. Doi: https://doi.org/10.1007/s40267-020-00785-z PMid:33041621 PMCid:PMC7532737
Kumar S. Second wave of COVID-19: emergency situation in India. J Travel Med. 2021 Oct 11;28(7):taab082. Doi: https://doi.org/10.1093/jtm/taab082 PMid:34037783 PMCid:PMC8244620
Joseph, N., Colaco, S. M., Fernandes, R. V., Krishna, S. G., & Veet-il, S. I. Perception and self-medication practices among the general population during the ongoing COVID-19 pandemic in Mangalore, India. Current drug safety 2022, 10.2174/1574886317666220513101349. Advance online publication. Doi: https://doi.org/10.2174/1574886317666220513101349 PMid:35570530
Onchonga D. A Google Trends study on the interest in self-medication during the 2019 novel coronavirus (COVID-19) disease pandemic. Saudi Pharm J. 2020 Jul;28(7):903-904. doi: 10.1016/j.jsps.2020.06.007. Epub 2020 Jun 18. PMID: 32641903; PMCID: PMC7299852. Doi: https://doi.org/10.1016/j.jsps.2020.06.007 PMid:32641903 PMCid:PMC7299852
Balboni E, Zagnoli F, Filippini T, Fairweather-Tait SJ, Vinceti M. Zinc and selenium supplementation in COVID-19 preven-tion and treatment: a systematic review of the experimental studies. J Trace Elem Med Biol. 2022 Feb 18;71:126956. Doi: https://doi.org/10.1016/j.jtemb.2022.126956 PMid:35217499 PMCid:PMC8853960
Elayeh E, Akour A, Haddadin RN. Prevalence and predictors of self-medication drugs to prevent or treat COVID-19: Experi-ence from a Middle Eastern country. Int J Clin Pract. 2021 Nov;75(11):e14860. Doi: https://doi.org/10.1111/ijcp.14860 PMid:34516713 PMCid:PMC8646359
Çimke S, Yıldırım GD. Determination of interest in vitamin use during COVID‐19 pandemic using Google Trends data: info-demiologystudy. Nutrition [Internet]. Elsevier Inc.; 2021;85:1‐7. Doi: https://doi.org/10.1016/j.nut.2020.111138 PMid:33578243 PMCid:PMC7797169
Wegbom AI, Edet CK, Raimi O, Fagbamigbe AF, Kiri VA. Self-medication practices and associated factors in the prevention and/or treatment of COVID-19 virus: a population-based survey in Nigeria. Front Public Heal. (2021) 9:606801. Doi: https://doi.org/10.3389/fpubh.2021.606801 PMid:34150693 PMCid:PMC8213209
Chindhalore, C. A., Dakhale, G. N., & Giradkar, A. B. (2020). Comparison of self-medication practices with analgesics among undergraduate medical and paramedical students of a tertiary care teaching institute in Central India - A question-naire-based study. Journal of education and health promo-tion, 9, 309. Doi: https://doi.org/10.4103/jehp.jehp_378_20 PMid:33426113 PMCid:PMC7774615
Pandolfi S, Simonetti V, Ricevuti G, Chirumbolo S. Paracetamol in the home treatment of early COVID-19 symptoms: a possi-ble foe rather than a friend for elderly patients? J Med Virol. 2021; 93:5704-6. Doi: https://doi.org/10.1002/jmv.27158 PMid:34170556 PMCid:PMC8426871
Paracetamol Paracetamol or ibuprofen can be used to treat the symptoms of COVID-19 says NHS, England,. Pharm J. Available online at: https://pharmaceutical-journal.com/article/news/ paracetamol-or-ibuprofen-can-be-used-to-treat-the-symptoms-of-covid-19-says-nhs-england (accessed April 20, 2020).
de Lusignan S, Joy M, Sherlock J, Tripathy M, van Hecke O, Gbinigie K, Williams J, Butler C, Hobbs FR. PRINCIPLE trial demonstrates scope for in-pandemic improvement in prima-ry care antibiotic stewardship: a retrospective sentinel net-work cohort study. BJGP Open. 2021 Oct 26;5(5):BJGPO.2021.0087. Doi: https://doi.org/10.3399/BJGPO.2021.0087 PMid:34312163 PMCid:PMC8596310
PRINCIPAL Trial Collaborative Group. Azithromycin for community treatment of suspected COVID-19 in people at in-creased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021 Mar 20;397(10279):1063-74. Doi: https://doi.org/10.1016/S0140-6736(21)00461-X PMid:33676597
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Princy Alpesh Patel, Jill Zalavadia , Ayushi Prajapati , Disha Jeram Pavasiya , Swati Patel, Neeta Sharma, Payal Naik
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
